AGP Picks
View all

AGP Executive Report

Last update: 10 hours ago

Vaccine Trial: Guinea-Bissau’s health minister says the government has not authorized a proposed hepatitis B study involving 14,000 newborns, despite reports that Danish researchers’ revised protocol received approval. The trial would delay the birth dose for half the babies until six weeks of age; the US health department also says it has not been approved. The ministry says research involving children must meet national law and international ethics standards.

Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.

AGP Wire

fallback image
Oct. 13, 2026

Stand Up for Science pushes Congress to halt CDC vaccine study in Guinea-Bissau

AGP

fallback image
Oct. 8, 2026

Stand Up for Science blasts CDC plan to revive Guinea-Bissau vaccine study

AGP

fallback image
Sep. 7, 2026

ROX opens Abu Dhabi AI manufacturing center, starts local vehicle production

AGP

fallback image
Aug. 21, 2026

Senegal backs MSGBC Oil, Gas & Power 2026 in Dakar

AGP


Perspectify logo Perspectify News

Learn about labels.

Labels
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate Press Release Service
filter

Filter

Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Press Release Service
Guinea-Bissau Has Not Approved Hep B Vaccine Trial in Newborns

Guinea-Bissau Has Not Approved Hep B Vaccine Trial in Newborns

How a Controversial Hepatitis B Study Was Funded by the CDC Amid a Global Swirl of Criticism

How a Controversial Hepatitis B Study Was Funded by the CDC Amid a Global Swirl of Criticism


fallback image
Oct. 13, 2026

Stand Up for Science Launches Petition to Halt CDC Vaccine Study in West Africa

EIN Presswire

fallback image
Oct. 8, 2026

Stand Up for Science Condemns CDC’s Attempts to Restart Controversial Vaccine Study in Guinea-Bissau

EIN Presswire

fallback image
Feb. 22, 2026

Guinea-Bissau Stops Trump-Backed Hepatitis B Vaccine Study

MENAFN

fallback image
Feb. 22, 2026

Guinea-Bissau Stops US-Funded Hepatitis B Vaccine Trial

MENAFN

fallback image
Sep. 29, 2026

Itafos Enhances Financial Flexibility and Liquidity with an Amendment and Extension of Its Existing Credit Facilities

GlobeNewswire, Inc.

fallback image
Feb. 17, 2026

STAND UP FOR SCIENCE CONDEMNS U.S.-FUNDED HEPATITIS B STUDY IN GUINEA-BISSAU

EIN Presswire

More press releases

Video Stories

YouTube video thumbnail:  Controversial US-Backed Hepatitis B Vaccine Trial to Move Forward in Guinea-Bissau
Play
Controversial US-Backed Hepatitis B Vaccine Trial to Move Forward in Guinea-Bissau
YouTube video thumbnail:  Centre Showcasing Black and African Culture Opens in London
Play
Centre Showcasing Black and African Culture Opens in London
Affinity Group Publishing Logo Showcase
Discover Affinity Group Publishing
YouTube video thumbnail:  Fearing Ebola, Mothers and Children in DRC Skip Vital Care
Play
Fearing Ebola, Mothers and Children in DRC Skip Vital Care
YouTube video thumbnail:  Rwanda and the EU: Who Benefits From Deportation Deals?
Play
Rwanda and the EU: Who Benefits From Deportation Deals?

Video Title

Sign up for:

Guinea Bissau Tech Digest

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

globe

Explore More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Guinea Bissau Tech Digest

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.